White House nears deal to lower prices for weight loss drugs Wegovy and Zepbound
The Trump administration is preparing to announce a deal this week with Eli Lilly and Novo Nordisk to lower the price of their weight loss drugs, a person familiar with the plan said.
White House nears deal to lower obesity drug prices for Medicare coverage
The GLP-1 drugs, produced by Novo Nordisk and Eli Lilly, have been credited with helping weight-loss, preventing diabetes and other positive effects.
After the FDA crackdown, here’s how some companies are still selling GLP-1s
Microdosing isn’t just about mushrooms any more. While taking tiny non-psychedelic doses of hallucinogens was once the health craze du jour, small, sub-clinical doses of weight loss drugs have taken over the term “microdosing” in 2025. Little research has been done on the efficacy of GLP-1 drugs like Ozempic when prescribed in smaller doses, but […]
The race is on to turn your body into a GLP-1 factory – CNN
The race is on to turn your body into a GLP-1 factory CNN
Medifast’s Q3 Loss Wider Than Expected, Sales Decline 36% Y/Y
Medifast, Inc. (MED) delivered third-quarter 2025 results, with the top line surpassing the Zacks Consensus Estimate while the bottom line missing the same. Both the metrics showed a year-over-year decline. Management is shifting its strategy from being a weight-loss company to becoming a leader in metabolic health. The company believes its coach-guided, clinically proven system […]
FEHB costs are climbing in 2026. Here’s what that means for feds
<![CDATA[ Unfortunately, the 12.3% average enrollee increase in FEHB premiums isn’t the only health insurance cost rising next year. Depending on your plan and providers, what you pay when you use medical services may also go up, sometimes significantly. Let’s walk you through the key benefit changes, highlight examples of what’s shifting, and point you […]
Aion Medicines Presents Data at ObesityWeek Demonstrating Ultra-long-acting Pharmacokinetics and Pharmacodynamic Effects of AM-710, a Potential Best-in-class GLP-1 Receptor Agonist and the Longest Acting Incretin Identified to Date
SAN FRANCISCO & ATLANTA–(BUSINESS WIRE)–Aion Medicines, a subsidiary of Exavir Therapeutics, announced the presentation of preclinical data for AM-710, the company’s ultra-long-acting small molecule GLP1R agonist, at the ObesityWeek conference in Atlanta, GA demonstrating the potential for a best-in-class profile and multi-month dosing intervals. “These impressive data demonstrate that AM-710 is a unique and highly […]
Bariatric Surgery May Cut Costs and Weight More Than GLP-1 Drugs
Despite growing prescription numbers and spending on glucagon-like peptide 1 (GLP-1) receptor agonists for obesity treatment, metabolic bariatric surgery may result in greater weight loss and lower costs, according to a recent study in JAMA Surgery. This comes as obesity experts have noticed decreased demand for the weight-loss surgery, which is often considered the “last […]
STAT+: News you need to know about AI medical coding and GLP-1 microdosing
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Telehealth companies Noom, Found, and Hims & Hers have all recently launched programs to prescribe “microdosed” GLP-1s. The companies say that in small doses […]
STAT+: Pharmalittle: We’re reading about FDA disarray, microdosing GLP-1 weight loss drugs, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a good start here on the Pharmalot campus, where we have cool breezes and clear blue skies greeting us today. Who could ask for anything more? Actually, we could — it is time to reheat the coffee kettle for […]